AI Tools Target Global Surge in Fatty Liver Disease

More than a billion people worldwide now have livers in which fat makes up at least 5 % of the organ’s weight—a level that triggers inflammation, cell damage, and fibrosis. The condition, known as fatty liver disease, affects roughly 30 % of adults and is increasingly seen in children. Because it usually produces no symptoms, most cases are diagnosed only after the disease has progressed to cirrhosis or life-threatening complications.

Wired Magazine

Researchers are exploring artificial-intelligence systems to identify high-risk individuals from existing medical data. Jeffrey Lazarus, a professor at the CUNY Graduate School of Public Health and Health Policy, argues that AI can scan massive volumes of electronic health records and laboratory results to flag patients whose liver fat may be accumulating unnoticed. By prioritizing these patients for further testing, AI could enable earlier intervention before severe scarring develops.

Wired Magazine

If left unchecked, fatty liver disease can lead to liver failure, heightened cardiovascular risk, and a range of cancers. Early detection through AI-driven screening could therefore reduce the burden of these downstream health outcomes and lower the need for emergency treatment of advanced liver disease.

Wired Magazine

Lazarus emphasizes that retrospective analysis of hospital visits and lab reports offers a practical pathway to target those most at risk. He suggests that health systems could integrate such AI tools into routine data pipelines, allowing clinicians to focus diagnostic resources on patients flagged by the algorithm.

Wired Magazine

• “AI can retrospectively go through massive numbers of hospital visits and lab reports,” — Jeffrey Lazarus

Wired Magazine